Nasal decongestants for the common cold

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2007, Pages

  Taverner, David ^a   Latte, J ^b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b NONE

Author keywords

Adult; Child; Common cold *drug therapy ; Female; Humans; Male; Nasal decongestants adverse effects; *therapeutic use ; Randomized controlled trials as topic

Indexed keywords

DECONGESTIVE AGENT; IBUPROFEN; NOREPHEDRINE; OXYMETAZOLINE; PHENYLPROPANOLAMINE; PLACEBO; PSEUDOEPHEDRINE;

COMMON COLD; DRUG EFFICACY; HUMAN; INSOMNIA; NOSE AIRWAY RESISTANCE; NOSE CONGESTION; REVIEW; RHINOMANOMETRY; SINGLE DRUG DOSE;

EID: 34548370620     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001953.pub3     Document Type: Review

References (61)

1. Akerlund 1989 {published data only} Akerlund A, Klint T, Olen L, Rundcrantz H. Nasal decongestant effect of oxymetazoline in the common cold: an objective dose-response study in 106 patients. Journal of Laryngology and Otology 1989;103 (8):743-6.
2. Cohen 1978 {published data only} Cohen BM. Clinical correlants of changes in nasal flow / resistance (Rn) measurements. Allergologia et Immunopathologia 1978;6(3):217-23. [MEDLINE: 79059299].
3. Eccles 2005 {published data only} Eccles R, Jawad MSM, Jawad SSM, Angello JT, Druce HM. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold. American Journal of Rhinology 2005;19(1):25-31.
4. Gronborg 1983 {published data only} Gronborg H, Winther B, Brofeldt S, Borum P, Mygind N. Effects of oral norephedrine on common cold symptoms. Rhinology 1983;21 (1):3-12.
5. Latte 2006 {published data only} Latte J, Taverner D. Clinical trial of 3 days treatment with of oral pseudoephedrine for the common cold in the southern hemisphere. In press 2006.
6. Sperber 1989 {published data only} Sperber SJ, Sorrentino JV, Riker DK, Hayden FG. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bulletin of the New York Academy of Medicine 1989;65(1):145-60.
7. Taverner 1999 {published and unpublished data} Taverner D, Danz C, Economos D. The effects of oral pseudoephedrine on nasal patency in the common cold: a double-blind single-dose placebo-controlled trial. Clinical Otolaryngology 1999;24:47-51.
8. Aschan 1964 Aschan G, Drettner B. An objective investigation of the decongestive effect of xylometazoline. The Eye, Ear, Nose and Throat Monthly 1964;43:66-74.
9. Bende 1984 Bende M, Andersson K, Johansson C, Sjogren C, Svensson G. Dose-response relationship of a topical nasal decongestant: phenylpropanolamine. Acta Otolaryngology (Stockholm) 1984;98:543- 7.
10. Berkowitz 1989 Berkowitz RB, Connell JT, Dietz AJ, Greenstein SM, Tinkelman DG. The effectiveness of the nonsedating antihistamine loratadine plus pseudoephedrine in the symptomatic management of the common cold. Annals of Allergy, Asthma & Immunology 1989;63:336-9.
11. Bucke 1982 Bucke B, Ottlewski G. Experiences with pseudoephedrine hydrochloride: A therapeutic agent [Erfahrungen mit pseudoehedrinhydrochlorid: Einem schleimhautabschwellenden Therapeutikum]. Zeitschrift fur Allgemeinmedizin 1982;58(26):1422-6.
12. Bye 1980 Bye E, Cooper J, Fowle ASE, Hughes DTD, Letley E, O'Grady J. Effects of pseudoephedrine and triprolidine, alone and in combination, on symptoms of the common cold. British Medical Journal 1980;281:189- 90.
13. Bye 1981 Bye CE, Cooper J, Empey DW, Fowle ASE, Hughes DTD, Letley B, et al.Therapeutic effects of pseudoephedrine and triprolidine, alone and in combination [Efectos terapéuticos de la pseudoefedrina y de la triprolidina, solas y en combinación, sobre la sintomatología del risfriado común]. Compendium de Investigaciones Clinicas Latinoamericanas 1981;1(3):9-13.
14. Caenen 2005 Caenen M, Hamels K, Deron P, Clement P. Comparison of decongestive capacity of xylometazoline and pseudoephedrine with rhinomanometry and MRI. Rhinology 2005;43(3):205-9.
15. Castellano 2002 Castellano F, Mautone G. Decongestant activity of a new formulation of xylometazoline nasal spray: A double-blind, randomized versus placebo and reference drugs controlled, dose-effect study. Drugs Under Experimental and Clinical Research 2002;XXVIII(1):27-35.
16. Cohen 1972 Cohen BM. Clinical and physiologic " significance" of drug-induced changes in nasal flow / resistance. European Journal of Clinical Pharmacology 1972;5:81-6.
17. Connell 1969 Connell JT. Effectiveness of topical nasal decongestants. Annals of Allergy 1969;27(11):541-6.
18. Dressler 1977 Dressler WE, Myers T, London SJ, Rankell AS, Poetsch CE. A system of rhinomanometry in the clinical evaluation of nasal decongestants. Annals of Otology Rhinology and Laryngology 1977;86(3 pt 1):310-7.
19. Erickson 2001 Erickson CH, McLeod RL, Mingo GG, Egan, RW, Pederson OF, Hey JA. Comparative Oral and topical Decongestant Effects of Phenylpropanolamine and d-Pseudoephedrine. American Journal of Rhinology 2001;15(2):83-90.
20. Gallardo 1994 Gallardo FM, Fiesco AL, Zamora G. Symptomatic treatment of common cold in children with a new combination of naproxen sodium plus pseudoephedrine hydrochloride: A comparative trial against pseudoephedrine syrup. Proceedings of the Western Pharmacology Society 1994;37:157-8.
21. Good 1952 Good MG. New approach to the treatment and prophylaxis of colds. British Journal of Physical Medicine, Including its Application to Industry 1952;15(7):163-6.
22. Good 1953 Good MG. New approach to treatment and prophylaxis of colds. Journal of Indian Medical Association 1953;22(8):244-7. [MEDLINE: ISSN 0019-5847].
23. Hamilton 1981 Hamilton LH. Effect of xylometazoline nasal spray on nasal conductance in subjects with coryza. The Journal of Otolaryngology 1981;10 (2):109-16.
24. Hendley 1994 Hendley JO, Abbott RD, Beasley PP, Gwaltney JM Jr. Effect of inhalation of hot humidified air on experimental rhinovirus infection [see comments]. JAMA 1994;271(14):1112-3.
25. Hummel 1998 Hummel T, Rothbauer C, Pauli E, Kobal G. Effects of the nasal decongestant oxymetazoline on human olfactory and intranasal trigeminal function in acute rhinitis. European Journal of Clinical Pharmacology 1998;54(7):521-8.
26. Jawad 1998 Jawad SSM, Eccles R. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology 1998;36:73-6.
27. Kolsch 2004 Kolsch S, Tschaikin M. Oxymetazoline against common cold [Oxymetazolin gegen schnupfen]. Deutsche Apotheker-Zeitung 2004; 144(45):95-7. [MEDLINE: ISSN 0011-9857].
28. Lea 1984 Lea P. A double-blind controlled evaluation of the nasal decongestant effect of Day Nurse in the common cold. Journal of International Medical Research 1984;12(2):124-7.
29. Lewison 1970 Lewison E. Comparison of the effectiveness of topical and oral nasal decongestants. The Eye, Ear, Nose and Throat Monthly 1970;49:42-4.
30. Maranta 1996 Maranta CA, Simmer D. Decongestant nasal spray [Abschwellende nasensprays]. Schweizerische Medizinisch Wochenschrift 1996;126 (44):1875-80.
31. McLaurin 1961 McLaurin JW, Shipman WF, Rosedale R Jr. Oral decongestants. A double blind study of the effectiveness of four sympathomimetic drugs: objective and subjective. Laryngoscope 1961;71:54-67.
32. Meurman 1975 Meurman OH, Rantanen T. A controlled Clinical Comparison of nasal Decongestants in Acute Rhinitis. The Journal of International Medical Research 1975;3:356-62.
33. Michel 1996 Michel FB. Multisymptom management in the common cold. International Pharmacy Journal 1996;10(5):4-9.
34. Peter 1972 Peter M. Treatment of common cold with a new drug Co-Tylenol. Schweizerische Rundschau für Medizin Praxis 1972;61(20):682-3.
35. Roth 1977 Roth RP, Cantekin EI, Bluestone CD, Welch RM, Cho YW. Nasal decongestant activity of pseudoephedrine. Annals of Otology Rhinology and Laryngology 1977;86(2 pt 1):235-42.
36. Slodki 1965 Slodki SJ, Montgomery CA. Clinical comparison of oxymetazoline and ephedrine in nasal decongestion. Current Therapeutic Research 1975;7(1):19-22.
37. Sperber 2000 Sperber SJ, Turner RB, Sorrentino JV, O'Connor RR, Rogers J, Gwaltney JM. Effectiveness of pseudoephedrine plus acetaminophen for treatment of symptoms attributed to the paranasal sinuses associated with the common cold. Archives of Family Medicine 2000;9: 979-85.
38. Stillings 2003 Stillings M, Little S, Sykes J. Common cold and influenza symptom management: the use of pharmacokinetic considerations to predict the efficacy of a twice-daily treatment for colds and flu. Current Medical Research and Opinion 2003;19(8):791-9.
39. Turner 2005 Turner RB. New considerations in the treatment and prevention of rhinovirus infection. Pediatric Annals 2005;34(1): 53-7.
40. Weisberg 1966 Weisberg J, Breslow I. The evaluation of a nasal decongestant preparation. Archives of Otolaryngology 1966;83(5): 477-9.
41. Winther 1983 Winther B, Brofeldt S, Borum P, Pedersen M, Mygind N. Lack of effect on nasal discharge from a vasoconstrictor spray in common cold. European Journal of Respiratory Diseases Supplement 1983;128 (Pt 2):447-8.
42. Claudet 1997 Claudet I, Fries F. Intoxiation with nasal vasoconstrictors in neonates. A case report [Danger des vasoconstricteurs nasaux chez le nourrisson. A propos d'une observation]. Archives de Pediatrie 1997;4:538-41.
43. Clemens 1997 Clemens CJ, Taylor JA, Almquist JR, Quinn HC, Mehta A, Naylor GS. Is an antihistamine-decongestant combination effective in temporarily relieving symptoms of the common cold in preschool children?. Journal of Pediatrics 1997;130:463-6.
44. Clement 1984 Clement PA. Committee report on standardization of rhinomanometry. Rhinology 1984;22:151-5.
45. Criscione 1997 Criscione S, Porro E. Infectious agent-induced rhinitis. In: RaeburnD, GiembyczMA editor(s). Rhinitis: Immunopathology and Pharmacotherapy. Basel: Birkhauser Verlag, 1997:147-60.
46. Dickersin 1994 Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91.
47. Eccles 1990 Eccles R, Jawad MS, Morris S. The effects of oral administration of (-)-menthol on nasal resistance to airflow and nasal sensation of airflow in subjects suffering from nasal congestion associated with the common cold. The Journal of Pharmacy and Pharmacology 1990; 42:652-4.
48. Garibaldi 1985 Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults: Incidence, Etiology and Impact. American Journal of Medicine 1985;78(Suppl 6B):32-7.
49. Graf 1997 Graf P. Rhinitis medicamentosa: aspects of pathophysiology and treatment. Allergy 1997;52(Suppl):28-34.
50. Gwaltney 1996 Gwaltney JM, Buier RM, Rogers JL. The influence of signal variation, bias, noise and effect size on statistical significance in treatment studies of the common cold. Antiviral Research 1996;29:287-95.
51. Hendeles 2006 Hendeles L, Hatton RC. Oral phenylephrine: An ineffective replacement for pseudoephedrine?. Journal of Allergy & Clinical Immunology 2006;118(1):279-80.
52. Higgins 2005 Higgins JPT, Green S, editors. Analysing and presenting results. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 4. Chichester, UK: John Wiley & Sons, Ltd, 2005.
53. Ho 1997 Ho FN, Mursch JD, Ong BS, Perttula B. Consumer satisfaction with OTC drugs: an analysis using the confirmation/disconfirmation model. Health Marketing Quarterly 1997; Vol. 15, issue 1:103-17.
54. Hutton 1991 Hutton N, Wilson MH, Mellits ED, Baumgardner R, Wissow LS, Bonuccelli C, et al.Effectiveness of an antihistamine-decongestant combination for young children with the common cold: a randomized, controlled clinical trial. Journal of Pediatrics 1991;118:125-30.
55. Mohar 1995 Mohar D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists. Controlled Clinical Trials 1995; 16:62-73.
56. Morton 2003 Morton V, Torgerson DJ. Effect of regression to the mean on decision making in health care. BMJ 2003;326:1083-4.
57. Sankey 1984 Sankey RJ, Nunn AJ, Sills JA. Visual hallucinations in children receiving decongestants. British Medical Journal 1984;288:1369.
58. Smith 1993 Smith MB, Feldman W. Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991. JAMA 1993; 269:2258-63.
59. Thumin 1975 Thumin F, Wims E. The perception of the common cold, and other ailments and discomforts related to age. International Journal of Aging and Human Development 1975;6:43-9.
60. Vitezic 1994 Vitezic D, Rozmanic J, Franulovic J, Ahel V, Matexic D. Naphazoline nasal drops intoxication in children. Arhiv Za Higijenu Rada i Toksikologiju 1994;45:25-9.
61. Widdicombe 1997 Widdicombe J. Pathophysiology of the nose in rhinitis. In: RaeburnD, GiembyczMA editor(s). Rhinitis: Immunopathology and Pharmacotherapy. Basel: Birkhauser Verlag, 1997:26-7.